| ASSET | YEAR | % RETURN |
|---|---|---|
Pfizer (PFE) | 2005 | -12% |
Pfizer (PFE) | 2006 | 13.65% |
Pfizer (PFE) | 2007 | -9.01% |
Pfizer (PFE) | 2008 | -17.07% |
Pfizer (PFE) | 2009 | 7.17% |
Pfizer (PFE) | 2010 | -0.12% |
Pfizer (PFE) | 2011 | 27.4% |
Pfizer (PFE) | 2012 | 19.21% |
Pfizer (PFE) | 2013 | 23.98% |
Pfizer (PFE) | 2014 | 5.83% |
Pfizer (PFE) | 2015 | 6.68% |
Pfizer (PFE) | 2016 | 5.83% |
Pfizer (PFE) | 2017 | 15.12% |
Pfizer (PFE) | 2018 | 24.27% |
Pfizer (PFE) | 2019 | -5.76% |
Pfizer (PFE) | 2020 | 2.75% |
Pfizer (PFE) | 2021 | 66.42% |
Pfizer (PFE) | 2022 | -9.57% |
Pfizer (PFE) | 2023 | -41% |
Pfizer (PFE) | 2024 | -2.52% |
Pfizer (PFE) | 2025 | -10.23% |
